← Leaderboards
Thomas William Frazier
Quadrant Biosciences, Inc.
$1,224,838
Attributed
$2,272,357
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $820.8K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,272,357 · 3
By mechanism
R01$1,265,746 · 1
R42$621,969 · 1
R15$384,642 · 1
Top collaborators
- Charis Eng2 shared
- Qian Du1 shared
- Frank A Middleton1 shared
- Ying Ni1 shared
Most similar at Quadrant Biosciences, Inc.
Same institution · by research overlap
- Alexander Rajan$541,199
- Qian Du$207,323
Others in their field
Other Emerging Leaders on “Autism Spectrum Disorder”
- John Goodwin · Omnitec Solutions, Inc.$13,013,535
- Lindsay Lawer Shea · Drexel University$9,147,763
- Christine Ladd-Acosta · Johns Hopkins University$8,850,827
- Natasha Marrus · Washington University$8,139,165
- Kristen Lyall · Drexel University$7,543,960
- Harrison W Gabel · Washington University$7,060,288
Research focus
Autism Spectrum DisorderEtiologyCohortClinical PracticeLeadDiagnosisPrevalencePhenotypeProspectiveGenomicsComputer SoftwareGeneticMedicalChildEarly InterventionComorbidityAffectDevelopmental Delay DisordersAdoptedFamilyMental HealthInnovationCellsPublic Health
Grant awards (5)
Modeling Autism and Comorbid Cancer Risk in Individuals with Germline PTEN Mutations$347,740
R01 · FY2024 · HD
Modeling Autism and Comorbid Cancer Risk in Individuals with Germline PTEN Mutations$481,833
R01 · FY2023 · HD
Modeling Autism and Comorbid Cancer Risk in Individuals with Germline PTEN Mutations$436,173
R01 · FY2022 · HD
A Big Data Approach Toward the Development of New Quantitative Autism Severity Scores from Existing Instruments$384,642
R15 · FY2022 · MH · contact PI
Validation of a salivary miRNA diagnostic test for autism spectrum disorder$621,969
R42 · FY2020 · MH